The consortium brings together 9 leading European NMIs in the field, complemented by 3 universities, 3 large RTOs, 2 pharmaceutical company and 1 SME producing innovative nanotherapeutics, 1 hospital and the ETPN association are included in the consortium, providing the complementary expertise.